PLANT HEALTH CARE PLC |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3.82 GBX | +0.26% |
|
+7.00% | +3.52% |
| Apr. 22 | Plant Health Care hails Harpinab approval in Belgium | AN |
| Apr. 22 | Plant Health Care's Fertilizer Receives Belgian Approval | MT |
Summary
- The company presents an interesting fundamental situation from a short-term investment perspective.
Strengths
- Growth progress expectations are rather promising. Indeed, sales are expected to rise sharply in the coming years.
- With regards to fundamentals, the enterprise value to sales ratio is at 0.69 for the current period. Therefore, the company is undervalued.
- For several months, analysts have been revising their EPS estimates roughly upwards.
- The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
Weaknesses
- As a percentage of sales and without taking into account depreciation and amortization, the company has relatively low margins.
- The company has insufficient levels of profitability.
- For the last twelve months, sales expectations have been significantly downgraded, which means that less important sales volumes are expected for the current fiscal year over the previous period.
- For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
Ratings chart - Surperformance
Sector: Agricultural Chemicals
| 1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
|---|---|---|---|---|
| +3.52% | 16.25M | - | ||
| +0.63% | 15.02B | B+ | ||
| -17.37% | 13.81B | D+ | ||
| +3.13% | 12.19B | C | ||
| -15.34% | 9.72B | B+ | ||
| -11.77% | 7.35B | A- | ||
| -.--% | 7.31B | - | C- | |
| -5.39% | 6.35B | - | ||
| -5.36% | 4.18B | B- | ||
| -28.77% | 2.37B | D |
Investor Rating
Trading Rating
ESG Refinitiv
-
Financials
Sales growth
Earnings Growth
-
EBITDA / Sales
Profitability
Finances
Valuation
P/E ratio
-
EV / Sales
Price to Book
-
Price to Free Cash Flow
-
Yield
-
Momentum
1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision
Consensus
Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
-
12m Revision of opinion
-
Business Predictability
Analyst Coverage
Divergence of Estimates
-
Divergence of analysts' opinions
-
Divergence of Target Price
-
Earnings quality
Technical analysis
ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes
- Stock Market
- Equities
- PHC Stock
- Ratings Plant Health Care plc
